Antibacterial R&D is very hard! Two great pipeline reviews + an Industry-level view
Dear All (and with thanks to Stephan Harbarth for co-authoring this newsletter), A new review by Ursula Theuretzbacher and colleagues from GARDP provides an opportunity
4 April 2025 No Comments